Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ABBOTT LABORATORIES

(ABT)
  Report
Delayed Nyse  -  04:04 2022-09-27 pm EDT
98.33 USD   -1.51%
09/23Medical device makers see little impact from Fiona on Puerto Rico operations
RE
09/21North American Morning Briefing: Caution to Dominate Ahead of Fed; Putin Dials Up Nuclear Threat
DJ
09/20US FDA Commits to Strengthening Infant Formula Supply
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Goldman Sachs Adjusts Abbott Laboratories' Price Target to $104 From $111, Maintains Sell Rating

07/25/2022 | 12:17pm EDT


© MT Newswires 2022
All news about ABBOTT LABORATORIES
09/23Medical device makers see little impact from Fiona on Puerto Rico operations
RE
09/21North American Morning Briefing: Caution to Dominate Ahe..
DJ
09/20US FDA Commits to Strengthening Infant Formula Supply
MT
09/17Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technol..
PR
09/17Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technol..
CI
09/16MarketScreener's World Press Review : September 16, ..
MS
09/15Abbott Laboratories : Change in Directors or Principal Officers, Amendments to Articles of..
AQ
09/15Abbott Keeps Quarterly Dividend at $0.47 Per Share, Payable on Nov. 15 to Shareholders ..
MT
09/15Abbott Declares 395th Consecutive Quarterly Dividend
PR
09/15Abbott Declares Quarterly Common Dividend, Payable November 15, 2022
CI
More news
Analyst Recommendations on ABBOTT LABORATORIES
More recommendations
Financials (USD)
Sales 2022 42 514 M - -
Net income 2022 6 681 M - -
Net Debt 2022 6 183 M - -
P/E ratio 2022 26,4x
Yield 2022 1,88%
Capitalization 175 B 175 B -
EV / Sales 2022 4,26x
EV / Sales 2023 4,35x
Nbr of Employees 113 000
Free-Float 87,5%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 99,84 $
Average target price 124,89 $
Spread / Average Target 25,1%
EPS Revisions
Managers and Directors
Robert B. Ford Chairman, President, Chief Executive Officer & COO
Robert Emmett Funck Chief Financial Officer & Executive VP-Finance
Sabina Ewing Chief Investment Officer, VP-Business & Technology
Glenn Fletcher Tilton Independent Director
William A. Osborn Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ABBOTT LABORATORIES-29.06%174 842
MEDTRONIC PLC-21.38%108 100
BECTON, DICKINSON AND COMPANY-4.82%66 063
HOYA CORPORATION-20.78%33 709
DEXCOM, INC.-40.14%31 544
AMERISOURCEBERGEN CORPORATION2.60%28 260